arrow
Back
A

Avi Stein

John Hunter Hospital

25H-index
111Paper Count
1.8KCitation Count
Published Papers 16
Publication Date
Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab (vol 28, pg 761, 2017)
err2019-08-01
err1
errOAAI
errSwain, S. M.; Schneeweiss, A.; Gianni, L.; Gao, J. J.; Stein, A.; Waldron-Lynch, M.; Heeson, S.; Beattie, M. S.; Yoo, B.; Cortes, J.; Baselga, J.
errShare
errSave
Limited Field Noncontrast Computerized Tomography for Followup of Ureteral Stones: Initial Results
err2014-09-01
err2
PREAI
errFreifeld, Yuval; Stein, Avi; Avitan, Ofir; Mulner, Roni; Hashoul, Sharbel; May, Tal; Klein, Ilan Benyamin; Boyarsky, Leonid; Goldin, Dmitry; Mecz, Yoel; Peledt, Natan; Dekel, Yoram
errShare
errSave
IS TOTAL ABDOMINAL EXPOSURE DURING NON-CONTRAST COMUTERIZED TOMOGRAPHY (NCCT) NECESSARY AS FOLLOW -UP(F-U) OF PATIENTS WITH URETERAL STONES?!
err2013-04-01
err0
PREAI
errStein, Avi; Freifeld, Yuval; Avitan, Ofir; Molnar, Roni; Mecz, Yoel; Goldin, Dmitri; May, Tal; Klein, Ilan; Sharbal, Hashul; Yichie, Moad; Shnap, Mati; Peled, Nathan; Dekel, Yoram
errShare
errSave
Pretransplant Immunosuppression Confers Cancer Risks in Renal Transplantation
err2012-11-01
err0
errOAAI
errHibberd, A. D.; Trevillian, P. R.; Wlodarczyk, J. H.; Kemp, D. G.; Heer, M. K.; Stein, A. M.; Gillies, A. H.; Sheil, A. R.
errShare
errSave
Predominant expression of CCL2 at the tumor site of prostate cancer patients directs a selective loss of immunological tolerance to CCL2 that could be amplified in a beneficial manner (vol 184, pg 1092, 2010)
err2010-05-01
err0
errOAAI
errIzhak, Liat; Wildbaum, Gizi; Weinberg, Uri; Shaked, Yuval; Alami, Jennifer; Dumont, Daniel; Friedman, Boris; Stein, Avi; Karin, Nathan
errShare
errSave
Predominant Expression of CCL2 at the Tumor Site of Prostate Cancer Patients Directs a Selective Loss of Immunological Tolerance to CCL2 That Could Be Amplified in a Beneficial Manner
err2009-12-27
err42
errOAAI
errIzhak, Liat; Wildbaum, Gizi; Uri, Weinberg; Shaked, Yuval; Alami, Jennifer; Dumont, Daniel; Stein, Avi; Karin, Nathan
errShare
errSave
Hyperbaric oxygen therapy for radiation-induced haemorrhagic cystitis
err2005-06-17
err48
PREAI
errNeheman, A; Nativ, O; Moskovitz, B; Melamed, Y; Stein, A
errShare
errSave
MAGE-A8 overexpression in transitional cell carcinoma of the bladder: identification of two tumour-associated antigen peptides
err2004-06-22
err20
errOAAI
errBar-Haim, E; Paz, A; Machlenkin, A; Hazzan, D; Tirosh, B; Carmon, L; Brenner, B; Vadai, E; Mor, O; Stein, A; Lemonnier, FA; Tzehoval, E; Eisenbach, L
errShare
errSave
Molecular analysis of transitional cell carcinoma using cDNA microarray
err2003-10-23
err46
PREAI
errMor, O; Nativ, O; Stein, A; Novak, L; Lehavi, D; Shiboleth, Y; Rozen, A; Berent, E; Brodsky, L; Feinstein, E; Rahav, A; Morag, K; Rothenstein, D; Persi, N; Mor, Y; Skaliter, R; Regev, A
errShare
errSave
Interleukin-2, interferon-α, 5-fluorouracil, and vinblastine in the treatment of metastatic renal cell carcinoma -: A prospective phase II study:: The experience of Rambam and Lin Medical Centers 1996-2000
errCANCER
IF5.1
err2002-10-03
err20
errOAAI
errGez, E; Rubinov, R; Gaitini, D; Meretyk, S; Best, LA; Native, O; Stein, A; Erlich, N; Beny, A; Zidan, J; Haim, N; Kuten, A
errShare
errSave
Activated status of tumour-infiltrating lymphocytes and apoptosis in testicular seminoma
err2001-10-24
err49
PREAI
errYakirevich, E; Lefel, O; Sova, Y; Stein, A; Cohen, O; Ben Izhak, O; Resnick, MB
errShare
errSave
Urinary cytokeratin 20 as a marker for transitional cell carcinoma
err2000-01-01
err47
PREAI
errRotem, D; Cassel, A; Lindenfeld, N; Mecz, Y; Sova, Y; Resnick, M; Stein, A
errShare
errSave
errShare
errSave